Status:
COMPLETED
The Exploratory Clinical Trials for the Feasibility, Primary Safety and Efficacy of Foldable Capsular Vitreous Body
Lead Sponsor:
GuangZhou WeiShiBo Biotechnology Co., ltd
Collaborating Sponsors:
Sun Yat-sen University
Conditions:
Retinal Detachment
Eligibility:
All Genders
10-65 years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of this study is to determine the feasibility, primary safety and efficacy of foldable capsular vitreous body (FCVB) in the treatment of retinal detachment.
Detailed Description
Pars plana vitrectomy (PPV) has been one of the most important ophthalmic surgeries for treating a number of blinding diseases by removing and replacing the diseased vitreous body. Current clinic vitr...
Eligibility Criteria
Inclusion
- Refractive error less than ±3D
- Visual acuity worse than finger count
- Ocular perforating injuries, traumatic retinal detachment, giant retinal tear with PVR, serious than grade D PVR, ocular axial length is 16 to 25mm
- Signed the informed consent form
Exclusion
- Serious heart, lung, liver and kidney dysfunction
- Serious eye inflammation
- Silicone oil filled eyes
- The contralateral eye is non-functional
- Patients with diseases that the researchers consider not suitable participated in this clinical trial
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00910702
Start Date
May 1 2009
End Date
March 1 2013
Last Update
April 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China, 510060